Search Results - "BERSIGA, A"

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer by BOTTINI, A, BERRUTI, A, BETRI, E, BERTOLI, G, ALQUATI, P, DOGLIOTTI, L, BERSIGA, A, BRIZZI, M. P, BRUZZI, P, AGUGGINI, S, BRUNELLI, A, BOLSI, G, ALLEVI, G, GENERALI, D

“…The association between tumour shrinkage and reduction in kinetic cell activity after primary chemotherapy in human breast cancer is still a matter of…”
Get full text

Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis by Giordano, G, Bersiga, A, Marchetti, G, Melpignano, M

“…A case of primary adenocarcinoma of the rectovaginal septum (PARVS) is reported with clinical and pathological findings. A 37-year-old Caucasian woman with a…”
Get more information

Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial by Bottini, A, Berruti, A, Brizzi, M P, Bersiga, A, Generali, D, Allevi, G, Aguggini, S, Bolsi, G, Bonardi, S, Tondelli, B, Vana, F, Tampellini, M, Alquati, P, Dogliotti, L

“…This study was designed to address whether simultaneous primary chemo-hormonal therapy provides additional activity compared with chemotherapy alone in breast…”
Get full text

Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin® are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study by Sapino, A., Montemurro, F., Marchiò, C., Viale, G., Kulka, J., Donadio, M., Bottini, A., Botti, G., dei Tos, A.P., Bersiga, A., Di Palma, S., Truini, M., Sanna, G., Aglietta, M., Bussolati, G.

“…Biotin-labeled trastuzumab (BiotHER) can be used to test for HER2 by immunohistochemistry. We previously showed that BiotHER immunoreactivity is highly…”
Get full text

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer by BOTTINI, A, BERRUTI, A, ALQUATI, P, DOGLIOTTI, L, BRIZZI, M. P, BERSIGA, A, GENERALI, D, ALLEVI, G, AGUGGINI, S, BOLSI, G, BONARDI, S, BERTOLI, G

“…The purpose of this study was to evaluate whether tumour response to primary chemotherapy in human breast cancer is influenced by baseline haemoglobin (Hb)…”
Get full text

Morphological Evidence of Neutrophil-Tumor Cell Phagocytosis (Cannibalism) in Human Gastric Adenocarcinomas by Caruso, R. A., Muda, A. O., Bersiga, A., Rigoli, L., Inferrera, C.

“…The phenomenon of neutrophil-tumor cell emperipolesis or phagocytosis has been documented by light microscopy in various human carcinomas, but little is known…”
Get full text

p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens by Bottini, A., Dogliotti, L., Bersiga, A., Brizzi, M. P., Berruti, A.

Get full text

Eosinophil-tumor cell interaction in advanced gastric carcinoma: an electron microscopic approach by Caruso, R A, Bersiga, A, Rigoli, L, Inferrera, C

“…Tumor-associated tissue eosinophils have been observed in human tumors and experimental tumor models, but their function is poorly understood. One case of…”
Get more information

Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours by Bottini, A, Berruti, A, Bersiga, A, Brunelli, A, Brizzi, M P, Marco, B D, Cirillo, F, Bolsi, G, Bertoli, G, Alquati, P, Dogliotti, L

“…The administration of neoadjuvant chemotherapy to breast cancer (BC) patients with operable disease allowed studies aimed of exploring the interaction between…”
Get more information

Cytotoxic and antiproliferative activity of the CMF regimen administered in association with tamoxifen as primary chemotherapy in breast cancer patients by Bottini, A, Berruti, A, Bersiga, A, Brunelli, A, Brizzi, M P, Di Marco, B, Cirillo, F, Tampellini, M, Bolsi, G, Aguggini, S, Betri, E, Filippini, L, Bertoli, A, Alquati, P, Dogliotti, L

“…Seventy six consecutive patients with T2-4, N0-1, M0 primary breast cancer (BC) received a median of 3 cycles of CMF (cyclophosphamide, methotrexate,…”
Get more information

P3-07-25: Sentinel Lymph Node Mapping in Breast Cancer after Primary Chemotherapy by Bonardi, S, Andreis, D, Allevi, G, Aguggini, S, Milani, M, Generali, D, Bersiga, A, Brizzi, MP, Dogliotti, L, Berruti, A, Bottini, A

“…Abstract Background The High false negativity rate and the possible of interference of primary systemic treatment (PST) and biopsy on the lymphatic drainage in…”
Get full text

Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial Design by Generali, Daniele, Berruti, Alfredo, Foroni, Chiara, Bazzola, Letizia, Andreis, Daniele, Allevi, Giovanni, Bersiga, Alessandra, Dogliotti, Luigi, Fox, Stephen B., Harris, Adrian L., Bottini, Alberto

“…Breast cancer is a heterogeneous disease. Predictive molecular markers are crucial in patient management, but the only recommended predictive biomarkers are…”
Get full text

Nd: YAG laser treatment of vesical leiomyosarcoma by Gaboardi, F, Bordinazzo, R, Bersiga, A, Galli, L

“…The first in the literature of bladder leiomyosarcoma, treated by transurethral resection followed by laser irradiation, in a 75-year-old woman is reported. At…”
Get more information

p53 but not bcl-2 Immunostaining Is Predictive of Poor Clinical Complete Response to Primary Chemotherapy in Breast Cancer Patients by BOTTINI, A, BERRUTI, A, FILIPPINI, L, BETRI, E, BERTOLI, G, ALQUATI, P, DOGLIOTTI, L, BERSIGA, A, BRIZZI, M. P, BRUNELLI, A, GORZEGNO, G, DIMARCO, B, AGUGGINI, S, BOLSI, G, CIRILLO, F

“…Preoperative chemotherapy administered to breast cancer (BC) patients is a model for studying in vivo the interaction between cytotoxic treatment and clinical…”
Get full text

Down-regulation of HIF-1α expression by letrozole in ER+ ve breast cancer patients by Generali, D. G., Berruti, A., Fox, S. B., Brizzi, M., Bonardi, S., Milani, M., Bersiga, A., Dionisio, R., Dogliotti, L., Bottini, A., Harris, A. L.

“…Abstract only 510 Introduction: Letrozole is a selective non steroidal aromatase inhibitor (AI) used for the treatment of estrogen positive (ER+ve)…”
Get full text

Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapy by BODINI, Maria, BERRUTI, Alfredo, AGUGGINI, Sergio, TAMPELLINI, Marco, ALQUATI, Palmiro, OLIVETTI, Lucio, DOGLIOTTI, Luigi, BOTTINI, Alberto, ALLEVI, Giovanni, FIORENTINO, Carla, BRIZZI, Maria Pia, BERSIGA, Alessandra, GENERALI, Daniele, VOLPI, Davide, MARINI, Ugo

“…To investigate whether magnetic resonance imaging (MRI) is superior to clinical palpation in the assessment of response of breast cancer to primary…”
Get full text

Osteoclastoma-like giant-cell tumor of the liver. Case report by Andreola, S, Lombardi, L, Scurelli, A, Bersiga, A

Get more information

Changes in Microvessel Density As Assessed by CD34 Antibodies after Primary Chemotherapy in Human Breast Cancer by BOTTINI, Alberto, BERRUTI, Alfredo, SCARATTI, Lorena, BERTOLI, Giovanni, ALQUATI, Palmiro, DOGLIOTTI, Luigi, BERSIGA, Alessandra, BRIZZI, Maria Pia, ALLEVI, Giovanni, BOLSI, Giovanna, AGUGGINI, Sergio, BRUNELLI, Antonio, BETRI, Enrico, GENERALI, Daniele

“…Background: Several papers have shown that quantitationof tumor angiogenesis in primary breast cancer by counting blood vessels gives an independent assessment…”
Get full text

Primary letrozole therapy versus the combination of letrozole plus oral cyclophosphamide in elderly breast cancer patients. A single Institution randomized phase II trial by Bottini, A., Generali, D., Berruti, A., Brizzi, M. P., Allevi, G., Bonardi, S., Bersiga, A., Aguggini, S., Milani, M., Dionisio, R., Dogliotti, L.

“…Abstract only…”
Get full text

Clinicopathological features of early gastric cancer in younger versus older patients in a high incidence area of northern Italy by Caruso, R A, Finocchiaro, G, Bersiga, A, Fedele, F, Betri, E, Rigoli, L, Inferrera, C

“…The relationship between the clinicopathological features of early gastric cancer and age were analysed in a retrospective study of 168 patients. 168 patients,…”
Get more information